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Under in vitro conditions that mimic use of the drug in its phar-
maceutical vehicle, Lebwohl and coauthors (p. 594) describe ex-
tensive degradation induced by ultra-violet light on the Vitamin
D derivative calcitriol (Lebwohl et al, 2003). Not only was the ex-
tent of degradation greater than 90%, but also it occurred in a
period of 10 minutes. Control samples in ambient light were rela-
tively stable. The authors also show that calcitriol is able to absorb
UV radiation and e¡ectively reduce transmission of both UVA
and UVB wavelengths. The discussion and conclusion of the
authors strongly recommend that in choosing combination thera-
pies of calcitriol and light for the treatment of psoriasis that the
light be administered before application of the vitamin D deriva-
tive.This phenomenon has been reported previously with another
vitamin D analog, calcipotriene (Lebwohl et al, 1997). Cursory in-
spection of the chemical structures of vitamin D based drugs (Fig
1a) reveals an array of conjugated double bonds that absorb in the
UV with a l max 264 nm. It is not surprising, therefore, that
when exposed to UV light such molecules absorb and can under-
go chemical changes.
The questions raised by this in vitro report are far-reaching, and
the authors allude to the possibility that the degradation products
generated by photo-transformation may possess pharmacologic
activity. In the case of this highly potent Vitamin D3 derivative
the quantity of active drug in each gram of ointment is only 3
micrograms; consequently it becomes a challenging task to deter-
mine if indeed tiny quantities of conversion products may be
linked to pharmacological properties of the drug in the skin. An-
other lesson from this study is that direct exposure of vitamin D
treated skin to sunlight should be avoided.
The interaction of topically applied drugs with UV light is not
uncommon since the presence of conjugated double bonds in
drug actives lends them to have stability problems in the presence
of UV light. Tretinoin, all trans retinoic acid, is another light sen-
sitive molecule by nature of the array of conjugated double bonds
(Fig 1b). In a study carried out with tretinoin applied to primate
skin (Lehman et al, 1988), it was demonstrated that extensive con-
version to 13 is-retinoic acid (iso tretinoin) was observed. The re-
sults prompted speculation about the role of iso tretinoin in
Figure1. Chemical structure of active ingredients. a) Calcitriol; b) Tretinoin; c) Anthralin; d) Nafti¢ne; e) Adapalene; f ) Buteni¢ne
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topical therapy of acne. However, in a controlled clinical study
the activity of iso tretinoin was not superior to that of tretinoin.
It was shown that UV irradiation degraded up to 60% the reti-
noids Tretinoin, iso tretinoin and etretinate when applied topi-
cally ex vivo to monkey skin. In addition the drugs and their
breakdown products could be measured in the epidermis and der-
mis. In vitro light stability studies (Nyirady et al, 2002) were car-
ried out comparing a simple gel and a microsphere-based
formulation containing tretinoin. Under ambient (£uorescent)
light tretinoin was decomposed in both cases. Importantly, how-
ever, the microsphere tretinoin preparation was found to be more
stable to light then the classic gel.
Another example of photo instability is provided by the anti
psoriatic drug anthralin or dithranol (Fig 1c). A study byThoma
(Thoma & Holzmann, 1998) reported the rate and extent of
photo degradation in solution and in topical pharmaceutical ex-
cipients. A xenon lamp was used to produce arti¢cial sunlight.
Sensitivity to light was strongly dependent on the nature of the
solvent. Of interest from the therapeutic standpoint is that an-
thralin was highly unstable to light in para⁄n, a commonly used
exipient in therapeutic preparations, in contrast to its having
good stability in the dark.
In another example, Thoma (Thoma et al, 1997) reported the
photo stability of a series of antimycotic drugs in solution and
in cream formulations. Nati¢ne hydrochloride (Fig 1d) was ra-
pidly degraded in 2 to 3 h following exposure to arti¢cial sun-
light and was shown to photo-degrade to di¡erent products
depending on whether the drug was presented in solution or in
an oil in water emulsion system. Consequently the nature of the
formulation can in£uence photo-degradation, thus adding
further complexity to the question of drug stability on the skin
in the presence of light. This chemical observation leads once
again to the relevant discussion in the context of use conditions.
The relevance of these in vitro observations to practical applica-
tion warrants discussion.While the active pharmaceutical ingredi-
ents discussed in this commentary are shown to be stable ‘‘in
the tube,’’ as indicated by the approved shelf-life and storage
conditions, the issue that Lebwohl and co workers raise and that
merits re-examination is of paramount importance to our under-
standing of drug action in the context of human skin under use
conditions. Attention is focused on potential metabolic transfor-
mations in skin layers; however, the extent of such conversions is
often low. In contrast, light-induced decomposition of photo-la-
bile drugs for topical use can be quite extensive, as described
above. This obviously dictates the preferred sequence of applica-
tion if combination therapy of drugs with light sources is con-
templated. The nature of breakdown products should be
determined for another reason. The clinical e⁄cacy may be
mediated through one of the breakdown products and so our un-
derstanding of the mechanism of action of these drugs may be
enhanced. One consequence of this phenomenon is of strategic
relevance to the ‘‘drug designers’’. The fact that aromatic double
bonds are more stable to light than nonaromatic double bonds
led to the development of the constrained analogs of tretinoin
and nafti¢ne, namely adapalene (Fig 1e) and buteni¢ne (Fig 1f),
respectively.
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